ArticleThe EMBO journal2007

The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.

Yi-Hung Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.